Patents by Inventor Erica Kahn

Erica Kahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTRUDED OCULAR INSERTS OR IMPLANTS AND METHODS THEREOF
    Publication number: 20240042713
    Abstract: The present invention is directed to a method of preparing a sustained release biodegradable ocular insert or implant comprising melt extruding or injection molding a polymer composition and an active agent to form an insert or implant suitable for administration to the body. e.g., ocular administration. The method comprises feeding the polymer composition and the active into an extruder; mixing the components in the extruder; extruding a strand; and cutting the strand into unit dose inserts or implants.
    Type: Application
    Filed: December 6, 2022
    Publication date: February 8, 2024
    Inventors: Peter JARRETT, Rami EL-HAYEK, Erica KAHN, Dinesh HASWANI, Eric DICKINSON, Timothy S. JARRETT, Michael MCGRATH
  • OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
    Publication number: 20230390189
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: October 26, 2021
    Publication date: December 7, 2023
    Inventors: Charles D. BLIZZARD, Arthur DRISCOLL, Rami EL-HAYEK, Michael GOLDSTEIN, Joseph IACONA, Peter JARRETT, Timothy S. JARRETT, Erica KAHN, Zachary LATTRELL
  • OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
    Publication number: 20230285282
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 14, 2023
    Publication date: September 14, 2023
    Inventors: Charles D. BLIZZARD, Arthur DRISCOLL, Rami EL-HAYEK, Michael GOLDSTEIN, Joseph IACONA, Peter JARRETT, Timothy S. JARRETT, Erica KAHN, Zachary LATTRELL
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20230118774
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: November 21, 2022
    Publication date: April 20, 2023
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor
    Patent number: 11534396
    Abstract: This invention relates to methods of treatment with a sustained release biodegradable ocular implant containing a tyrosine inhibitor dispersed in a hydrogel.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: December 27, 2022
    Assignee: Ocular Therapeutix, Inc.
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20220347094
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: May 13, 2022
    Publication date: November 3, 2022
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Ocular implant containing a tyrosine kinase inhibitor
    Patent number: 11439592
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: September 13, 2022
    Assignee: Ocular Therapeutix, Inc.
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20220079876
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 24, 2021
    Publication date: March 17, 2022
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
    Publication number: 20210308043
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 24, 2021
    Publication date: October 7, 2021
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell